Research Article
[Retracted] Efficacy of Aidi Injection and Brucea javanica Oil Emulsion Injection in Rectal Cancer during CapeOX Adjuvant Chemotherapy
Table 2
Patient characteristics of the three groups.
| | ADI group () | BJOEI group () | Control group () | | value |
| | Age (years) | | | | 1.270 | 0.283 | | Gender (%) | | | | 0.742 | 0.690 | | Male | 53 (66.25) | 58 (72.50) | 55 (68.75) | | | | Female | 27 (33.75) | 22 (27.50) | 25 (31.25) | | | | BMI (kg/m2) | | | | 1.060 | 0.348 | | Tumor length (cm) | | | | 0.393 | 0.676 | | Preoperative clinical stage (%) | | | | 4.715 | 0.318 | | I | 2 (2.50) | 0 (0.00) | 0 (0.00) | | | | II | 22 (27.50) | 20 (25.00) | 18 (22.50) | | | | III | 56 (70.00) | 60 (75.00) | 62 (77.50) | | | | ECOG performance status (%) | | | | 0.870 | 0.647 | | 0 | 66 (82.50) | 70 (87.50) | 69 (86.25) | | | | 1 | 14 (17.50) | 10 (12.50) | 11 (13.75) | | Baseline CEA level (%) | | | | 1.363 | 0.506 | | ≤4.5 ng/mL | 24 (30.00) | 19 (23.75) | 18 (22.50) | | | | >4.5 ng/mL | 56 (70.00) | 61 (76.25) | 62 (77.50) | | | | Surgical method (%) | | | | 1.195 | 0.879 | | Dixon | 60 (75.00) | 63 (78.75) | 61 (76.25) | | | | Miles | 8 (10.00) | 9 (11.25) | 10 (12.50) | | | | Hartmann | 12 (15.00) | 8 (10.00) | 9 (11.25) | | | | Histological differentiation (%) | | | | 2.292 | 0.682 | | Well | 11 (13.75) | 9 (11.25) | 13 (16.25) | | | | Moderate | 41 (51.25) | 43 (53.75) | 46 (57.50) | | | | Poor | 28 (35.00) | 28 (35.00) | 21 (26.25) | | |
|
|
